1. Catalog
  2. Editor-in-Chief Minds Unite: Shaping the Future of ...
Editor-in-Chief Minds Unite: Shaping the Future of Pain and Neuromodulation (NANS 2025)
Create Account
Availability
On-Demand
Expires on Jan 30, 2028
Cost
Active Member: $50.00
Non-Member: $75.00
Early Career Member: $50.00
Associate Member: $50.00
Trainee Member: $50.00
Industry Member: $50.00
Credit Offered
No Credit Offered

Recording Date: February 1, 2025

Expiration Date: January 30, 2028

This recorded session from the 2025 NANS Annual Meeting brings together Editors-in-Chief and editorial leaders from leading pain and neuromodulation journals for a thought-provoking discussion on the future of research, publishing, and scientific collaboration in the field. Faculty explore emerging priorities in neuromodulation research, opportunities for collaboration among journals and professional societies, and strategies for advancing high-quality evidence to support clinical practice.

Through expert panel discussions and audience engagement, learners will gain practical insights into preparing impactful manuscripts, selecting the most appropriate journal for submission, navigating the peer-review process, and responding effectively to editorial feedback. The session also examines common reasons manuscripts are rejected and discusses the evolving publishing landscape, including the challenges and opportunities presented by the growing number of pain and neuromodulation journals. In addition, the activity features oral abstract presentations highlighting innovative research in spinal cord stimulation technology and neuromodulation biomarkers.

To access the NANS eLearning Center and register for this content, log in using your NANS account username and password.

  • Have a NANS account? Click Login.
  • Need an account? Click Create Account and complete the form.
  • Questions about your NANS account? Email membership@nans.org or call (773) 648-7845 (Mon–Fri, 8:30 AM–5:00 PM CT).
Registration fees for this activity are nonrefundable. For additional details, please visit the NANS website to review the full refund policy.
Engineer, Executive, Fellow, Medical student, Neurosurgeon, Neurologist, Physician, Pain Medicine Physician, Physical Medicine and Rehab Physician, Researcher, Resident, Scientist

Following participation in this activity, learners will be able to:

  • Discuss future goals and priorities among premier pain and neuromodulation journals.
  • Discuss opportunities for collaboration and consolidation between premier pain and neuromodulation journals, while also discussing the advantages and disadvantages of having an abundance of pain journals.
  • Describe the steps in identifying the right journal for submission, approach to impactful revisions, and avoiding biggest pitfalls that lead to rejection.

Welcome
Ryan D'Souza, MD and Nasir Hussain, MD, MSc

Vision for Future Research in Neuromodulation
Robert Levy, MD, PhD

Collaboration Between Journals on Common Goals that Would Advance the Field (e.g. multi-society guidelines)
Michael Schatman, PhD

Preparation of an Impactful Manuscript 
Ryan D'Souza, MD
Nasir Hussain, MD, MSc
Christopher Gilligan, MD

Oral Abstract Presentation: Human-Sized Softening Multi-Electrode Arrays for Optimized Spinal Cord Stimulation
Pedro Emanuel Rocha Flores, PhD

Oral Abstract Presentation: Evoked Compound Action Potentials Across Spinal Cord Injury and Chronic Pain
Disa Sullivan    

Oral Abstract Presentation: Identifying SCS Trial Responders Immediately After Postoperative ECAP Dose-Controlled Closed-Loop Therapy Programming 
Jason Pope, MD

Closing Discussion
Ryan D'Souza, MD and Nasir Hussain, MD, MSc

Any faculty member not on the disclosure list has reported nothing to disclose.

Ryan D’Souza, MD | Planner and Speaker
Nevro: Contracted Research (Ongoing)|Saol Therapeutics: Contracted Research (Ongoing)

Christopher Gilligan, MD | Speaker
Biotronik: Consulting Fees (Ongoing)|Iliad Lifesciences: Consulting Fees (Ongoing)|Mainstay Medical: Consulting Fees (Ongoing)|Mainstay Medical: Stock Options (Ongoing)|Persica: Consulting Fees (Ongoing)|Saluda Medical: Consulting Fees (Ongoing)

Robert Hurley, MD, PhD | Speaker
Nevro: Contracted Research (Ongoing)|NIH/NIDA: Collaborative grant (U24) (Ongoing)

Robert Levy, MD, PhD | Speaker
Abbott/St. Jude Medical: Uncompensated Consultant (Ongoing)|Biotronik: Uncompensated Consultant (Ongoing)|Mainstay Medical: Uncompensated Consultant (Ongoing)|Nalu Medical: Uncompensated Consultant (Ongoing)|Nalu Medical: Stock Options (Ongoing)|Saluda Medical: Uncompensated Consultant (Ongoing)|Saluda Medical: Stock Options (Ongoing

Michael Schatman, PhD | Speaker
Apurano Pharma: Consulting Fees (Ongoing)

Pedro Emanuel Rocha Flores, PhD | Oral Abstract Presenter
BackStop Neural Inc: *Employee/Executive (Ongoing)

Jason Pope, MD | Oral Abstract Presenter
Abbott: Consulting Fees (Ongoing)|Abbott: Contracted Research (Ongoing)|Aurora Spine: Consulting Fees (Ongoing)|Aurora Spine: Contracted Research (Ongoing)|Aurora Spine: Own Stock (Ongoing)|Aurora Spine: Royalty (Ongoing)|Biotronik: Consulting Fees (Ongoing)|Biotronik: Contracted Research (Ongoing)|Celeri Health: Own Stock (Ongoing)|Mainstay: Consulting Fees (Ongoing)|Mainstay: Contracted Research (Ongoing)|Painteq: Consulting Fees (Ongoing)|Painteq: Contracted Research (Ongoing)|Painteq: Own Stock (Ongoing)|Saluda: Consulting Fees (Ongoing)|Saluda: Contracted Research (Ongoing)|Saluda: Stock Options (Ongoing)|Spark: Consulting Fees (Ongoing)|Spark: Own Stock (Ongoing)|SPR: Consulting Fees (Ongoing)|SPR: Contracted Research (Ongoing)|SPR: Stock Options (Ongoing)|Vertos: Consulting Fees (Ongoing)|Vertos: Contracted Research (Ongoing)|Vertos: Own Stock (Ongoing)|WISE: Consulting Fees (Ongoing)

This is activity is not eligible for CME credit.

Powered By